The state of Texas currently has 55 active clinical trials seeking participants for COVID19 research studies. These trials are conducted in various cities, including Houston, Dallas, San Antonio and Austin.
Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic
NCT06334731
Recruiting
Assess the incidence and rates of resistant pathogens prior to and during the COVID-19 pandemic.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/26/2024
Locations: Methodist Dallas Medical Center, Dallas, Texas
Conditions: COVID-19
Register for Updates
Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.
NCT05785390
Recruiting
The goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of NP-101 in treating high-risk participants who have tested positive for Covid-19. The main question[s] it aims to answer are: To evaluate the safety of NP-101, as well as establish the maximum tolerated dose in high risk Covid-19 positive patients. Participants will [describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items]. If there is... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/22/2024
Locations: Clinical Trial Network, Houston, Texas +1 locations
Conditions: COVID-19
Register for Updates
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
NCT04488081
Recruiting
The goal of this project is to rapidly screen promising agents, in the setting of an adaptive platform trial, for treatment of critically ill COVID-19 patients. In this phase 2 platform design, agents will be identified with a signal suggesting a big impact on reducing mortality and the need for, as well as duration, of mechanical ventilation.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/12/2024
Locations: DHR Health, Edinburg, Texas +1 locations
Conditions: COVID-19
Register for Updates
Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19
NCT05817045
Recruiting
This is a randomized, double-blind, sham controlled, stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older with Mild COVID-19 in the at-home setting.
Gender:
All
Ages:
40 years and above
Trial Updated:
03/11/2024
Locations: 330 - Clinical Trial Network, Houston, Texas +2 locations
Conditions: COVID-19
Register for Updates
Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
NCT05886816
Recruiting
Adults who do not have major health, kidney, gastrointestinal disease will be randomized to receive oral mitoquinone/mitoquinol mesylate (Mito-MES) versus placebo to prevent the development and progression of COVID-19 after high-risk exposure to a person with confirmed SARS-CoV-2 infection.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
03/07/2024
Locations: University of Texas Southwestern Medical Center, Dallas, Texas
Conditions: SARS-CoV Infection, COVID-19
Register for Updates
BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients
NCT04482595
Recruiting
This is a randomized, double-blinded, placebo-controlled, two-arm study to evaluate the safety and efficacy of BIO 300 Oral Suspension (BIO 300) as a therapy to improve lung function in patients that were hospitalized for severe COVID-19-related illness and continue to experience post-acute respiratory complications associated with Long-COVID after discharge. Patients will be randomized 1:1 to receive BIO 300 or placebo.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/27/2024
Locations: University of Texas Health Science Center at Houston, Houston, Texas +1 locations
Conditions: Pulmonary Fibrosis, COVID-19, Long COVID, Post-acute Respiratory Complications of COVID-19
Register for Updates
Cromolyn Sodium for Treatment of COVID-19 Pneumonia
NCT05077917
Recruiting
The study hypothesis is that cromolyn, when combined with standard COVID-19 treatment, will improve patient symptoms and reduce the number of days to improved quality of life. Investigators will study the effects of adding cromolyn to the standard treatment of hospitalized patients with COVID-19 pneumonia and who require supplemental oxygen. Cromolyn will be administered as a nebulized treatment four times a day for four days followed by intranasal administration for two weeks. Investigators ma... Read More
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
02/21/2024
Locations: University Medical Center of El Paso, El Paso, Texas
Conditions: COVID-19 Pneumonia, COVID-19 Respiratory Infection, Pneumonia, Viral
Register for Updates
The Impact of COVID-19 on Pulmonary Procedures
NCT05022446
Recruiting
This study investigates the changes in practice by pulmonary procedural programs across the United States as they faced the coronavirus pandemic. Information gathered from this study may help guide pulmonary programs on a wider scale and improve their practice. The study may also help researchers understand where they should focus research efforts to better respond to a pandemic in the future.
Gender:
All
Ages:
All
Trial Updated:
02/08/2024
Locations: M D Anderson Cancer Center, Houston, Texas
Conditions: COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Register for Updates
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children
NCT05639465
Recruiting
Racial and ethnic minority children who live in socioeconomically disadvantaged communities are disproportionately impacted by pandemic and climate-induced disasters. Although effective interventions have been designed to treat mental health related symptoms in post-disaster settings, accessible, empirically supported prevention interventions are needed to prevent the onset of mental and behavioral health issues among these children. Building on our preliminary findings, the proposed study exami... Read More
Gender:
All
Ages:
Between 8 years and 14 years
Trial Updated:
01/08/2024
Locations: Dickinson Independent School District, Dickinson, Texas +2 locations
Conditions: Emotional Distress, Prosocial Behavior, Pandemic, COVID-19, Coping Skills, Social Support
Register for Updates
Bioaerosol Sampling Device (BSD) Clinical Study
NCT06047067
Recruiting
The goal of this clinical trial is to learn about the bioaerosol sampling device (BSD) and how it can sample patient bioaerosols (breath) and patient's nares for the detection of COVID-19 viral particles in patients seeking to be tested for COVID-19.
Gender:
All
Ages:
5 years and above
Trial Updated:
09/14/2023
Locations: HDH Research, Houston, Texas +2 locations
Conditions: COVID-19
Register for Updates
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
NCT03808922
Recruiting
This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.
Gender:
All
Ages:
All
Trial Updated:
07/19/2023
Locations: Cook Children's, Fort Worth, Texas +4 locations
Conditions: Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised, COVID-19
Register for Updates
Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus
NCT05867017
Recruiting
Hospitalized patients with severe COVID-19 have an increased incidence of insulin resistance, impaired beta cell function, glucose intolerance (prediabetes), and overt type 2 diabetes (T2D) compared to non-hospitalized patients with COVID-19 and COVID-19 negative individuals on long-term follow up.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
07/13/2023
Locations: Texas Diabetes Institute - University Health System, San Antonio, Texas
Conditions: COVID-19, Diabete Mellitus
Register for Updates